Notes Payable (due April 30, 2026) Income Taxes Payable Interest Payable Notes Payable (due in 2031) Common Stock Retained Earnings Dividends Sales Revenue Interest Revenue Gain on Disposal of Plant Assets Bad Debt Expense Cost of Goods Sold Depreciation Expense Income Tax Expense Insurance Expense Interest Expense Other Operating Expenses Amortization Expense 15,840 0 0 50,400 72,000 91,584 17,280 1,296,000 0 0 0 907,200 0 0 0 0 88,992 NOVAK CORP. Income Statement For the Year Ended December 31, 2025 Sales Revenue Cost of Goods Sold Gross Profit Income From Operations Bad Debt Expense $ $ Novak Corp.'s unadjusted trial balance at December 1, 2025, is presented below. \begin{tabular}{|c|c|c|} \hline Salaries and Wages Expense & 158,400 & \\ \hline Total & $1,672,416 & $1,672,416 \\ \hline \end{tabular} Notes Payable (due April 30, 2026) Income Taxes Payable Interest Payable Notes Payable (due in 2031) Common Stock Retained Earnings Dividends Sales Revenue Interest Revenue Gain on Disposal of Plant Assets Bad Debt Expense Cost of Goods Sold Depreciation Expense Income Tax Expense Insurance Expense Interest Expense Other Operating Expenses Amortization Expense 15,840 0 0 50,400 72,000 91,584 17,280 1,296,000 0 0 0 907,200 0 0 0 0 88,992 NOVAK CORP. Income Statement For the Year Ended December 31, 2025 Sales Revenue Cost of Goods Sold Gross Profit Income From Operations Bad Debt Expense $ $ Novak Corp.'s unadjusted trial balance at December 1, 2025, is presented below. \begin{tabular}{|c|c|c|} \hline Salaries and Wages Expense & 158,400 & \\ \hline Total & $1,672,416 & $1,672,416 \\ \hline \end{tabular}